SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 57.51 |
| Enterprise Value ($M) | 77.85 |
| Book Value ($M) | -34.05 |
| Book Value / Share | -0.38 |
| Price / Book | -1.69 |
| NCAV ($M) | -38.79 |
| NCAV / Share | -0.43 |
| Price / NCAV | -1.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -6.51 |
| Return on Assets (ROA) | -1.04 |
| Return on Equity (ROE) | -4.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.22 |
| Current Ratio | 1.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.19 |
| Assets | 32.93 |
| Liabilities | 66.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 8.70 | 12.16 | |
| 13D/A | Manning Paul B | 49.90 | 241.17 | |
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| 35 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 53,830 | 201,548 | 26.71 | |
| 77,301 | 279,825 | 27.62 | |
| 166,166 | 464,551 | 35.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VCEL – Vericel Corporation | VERA – Vera Therapeutics, Inc. |
| VNDA – Vanda Pharmaceuticals Inc. | WVE – Wave Life Sciences Ltd. |
| XENE – Xenon Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io